A multicenter self-comparing study of enteral nutrition powder (AA) in the treatment of active Crohn's disease in children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026979

Enrollment

Unknown

Registered

2019-10-27

Start date

2019-11-15

Completion date

Unknown

Last updated

2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease

Interventions

Case series:Enteral nutrition powder (AA)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Aged 6-17 years old; 2) diagnosed with Crohn's disease; 3) PCDAI score >=10.

Exclusion criteria

Exclusion criteria: 1. Patients with enteral nutrition powder (AA) allergic history or other contraindications; 2. Complete mechanical ileus, gastrointestinal bleeding, severe abdominal infection; 3. Gastrointestinal dysfunction or some conditions requiring intestinal rest; 4. Severe diabetes or abnormal glucose metabolism; 5. Abnormal amino acid metabolism.

Design outcomes

Primary

Measure	Time frame
PCDAI<10;	—

Countries

China

Contacts

Public ContactQian, Jiaming

Peking Union Medical College Hospital

liyanjun@wanhe-phar.com+86 755 86152999-8351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026